NCT02798926

Brief Summary

Particular attention is paid to thermal management of preterm neonates in neonatal intensive care units because of the major risk of morbidity associated with hypothermia. Percutaneous central venous catheter placement is essential to ensure adequate caloric intake and intravenous administration of treatments, but this procedure can cause major body temperature variations, responsible for complications in these neonates, as convection incubator function is impaired during opening of the incubator, which can be prolonged (30 minutes to 2 hours) depending on the technical difficulties encountered during catheter placement. In parallel, the use of a polyethylene bag or sheet in the delivery room and for neonatal transport is now clearly defined and ensures stability or even a considerable temperature gain during transfer immediately after birth. In the light of several clinical cases, the use of a polyethylene bag during central venous catheter placement appears to be effective to prevent body temperature loss in preterm neonates. No data are currently available concerning the value of this method of prevention of hypothermia during this type of procedure. Preliminary studies conducted by our team on a dummy suggest that a polyethylene bag or sheet could be useful during this procedure by significantly reducing heat loss caused by convection and evaporation. However, compensation phenomena such as generalized vasoconstriction to cold in preterm infants are very poorly described, but can induce a functional conflict between mechanisms ensuring maintenance of homeostasis and those involved in maintenance of blood pressure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 19, 2014

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

June 9, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 14, 2016

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 23, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 23, 2022

Completed
Last Updated

June 12, 2026

Status Verified

June 1, 2026

Enrollment Period

8.2 years

First QC Date

June 9, 2016

Last Update Submit

June 11, 2026

Conditions

Keywords

hypothermiacentral venous catheter placementPolyethylene bag

Outcome Measures

Primary Outcomes (1)

  • Temperature

    difference between the prehepatic temperature at the beginning of catheter placement and the lowest temperature observed during the procedure

    1 hour

Study Arms (2)

with the use of a polyethylene bag

Device: polyethylene bag

without the use of a polyethylene bag

Interventions

The infant will be wrapped in a polyethylene bag 15 min before starting central venous catheter placement

with the use of a polyethylene bag

Eligibility Criteria

Age0 Days - 7 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

preterm neonates less than 32 weeks of gestational age (WGA)

You may qualify if:

  • premature Newborn child = 32 weeks of gestational age
  • days of life
  • Normothermic (core temperature between 36.5 and 37.5 ° C)
  • Stable on a hemodynamically manner
  • Need the installation of a central catheter KTEC

You may not qualify if:

  • Parental Refusal
  • hypothermia (temperature \< 36.5 ° C)
  • Hyperthermia (temperature \> 37.5 ° C)
  • heart disease and malformation syndromes life-threatening
  • Hemodynamic instability ( catecholamine vasoconstrictor and vasodilator )
  • Breakdown by oscillation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens

Amiens, 80054, France

Location

MeSH Terms

Conditions

Hypothermia

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Laurent GHYSELEN, PhD

    CHU Amiens

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2016

First Posted

June 14, 2016

Study Start

June 19, 2014

Primary Completion

August 23, 2022

Study Completion

August 23, 2022

Last Updated

June 12, 2026

Record last verified: 2026-06

Locations